As of 2026-01-02, the Relative Valuation of MEI Pharma Inc (MEIP) is 12.28 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.07 USD, the upside of MEI Pharma Inc based on Relative Valuation is 299.9%.
The range of the Relative Valuation is 9.82 - 14.73 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 21.6x - 32.4x | 27.0x |
| Fair Price | 9.82 - 14.73 | 12.28 |
| Upside | 219.9% - 379.9% | 299.9% |
| Date | P/E |